You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

List of Excipients in API sumatriptan


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing sumatriptan

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
GlaxoSmithKline LLC IMITREX sumatriptan 0173-0524 POTASSIUM PHOSPHATE, MONOBASIC
GlaxoSmithKline LLC IMITREX sumatriptan 0173-0524 SODIUM HYDROXIDE
GlaxoSmithKline LLC IMITREX sumatriptan 0173-0524 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
GlaxoSmithKline LLC IMITREX sumatriptan 0173-0524 SULFURIC ACID
GlaxoSmithKline LLC IMITREX sumatriptan 0173-0524 WATER
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing sumatriptan

Company Ingredient NDC Excipient
Hikma Pharmaceuticals USA Inc sumatriptan 0143-9638 SODIUM CHLORIDE
Hikma Pharmaceuticals USA Inc sumatriptan 0143-9638 WATER
Lannett Company Inc sumatriptan 0527-1818 POTASSIUM PHOSPHATE, MONOBASIC
Lannett Company Inc sumatriptan 0527-1818 SODIUM HYDROXIDE
Lannett Company Inc sumatriptan 0527-1818 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for sumatriptan

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BENZALKONIUM CHLORIDE

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CI 77492

Excipient focus: CI 77891

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

sumatriptan drug variants containing CROSPOVIDONE

Company Ingredient NDC
Mylan Pharmaceuticals Inc sumatriptan and naproxen sodium 0378-8755
NorthStar RxLLC sumatriptan and naproxen sodium 16714-891
Sun Pharmaceutical Industries Inc sumatriptan and naproxen sodium 47335-410
Aurobindo Pharma Limited sumatriptan and naproxen sodium 65862-928
Innovida Phamaceutique Corporation sumatriptan and naproxen sodium 71800-901
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: D&C RED NO. 27

Excipient focus: DEXTROSE MONOHYDRATE

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: DICALCIUM PHOSPHATE

Excipient focus: EDETATE DISODIUM

Excipient focus: FD&C BLUE NO. 2

sumatriptan drug variants containing FD&C BLUE NO. 2

Company Ingredient NDC
NorthStar RxLLC sumatriptan and naproxen sodium 16714-891
Sun Pharmaceutical Industries Inc sumatriptan and naproxen sodium 47335-410
Innovida Phamaceutique Corporation sumatriptan and naproxen sodium 71800-901
Rebel Distributors Corp sumatriptan succinate and naproxen sodium 21695-954
Currax Pharmaceuticals LLC sumatriptan succinate and naproxen sodium 42847-850
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: MANNITOL

Excipient focus: MONOBASIC POTASSIUM PHOSPHATE

Excipient focus: N-DODECYL .BETA.-D-MALTOSIDE

Excipient focus: PEG-20 SORBITAN OLEATE

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POTASSIUM PHOSPHATE, MONOBASIC

Excipient focus: POVIDONE

sumatriptan drug variants containing POVIDONE

Company Ingredient NDC
Mylan Pharmaceuticals Inc sumatriptan succinate 0378-5630
Golden State Medical Supply Inc sumatriptan succinate 51407-011
Rebel Distributors Corp sumatriptan succinate and naproxen sodium 21695-954
Currax Pharmaceuticals LLC sumatriptan succinate and naproxen sodium 42847-850
Currax Pharmaceuticals LLC dba Cypress Hawthorn Macoven sumatriptan succinate and naproxen sodium 44183-850
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POVIDONE K30

Excipient focus: POVIDONE K90

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BICARBONATE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM PHOSPHATE, DIBASIC ANHYDROUS

Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: SULFURIC ACID

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links